首页> 外文期刊>American Journal of Infectious Diseases and Microbiology >Re-Emerging Human Viral Hemorrhagic Fevers: A Review
【24h】

Re-Emerging Human Viral Hemorrhagic Fevers: A Review

机译:重新出现的人类病毒性出血热:回顾

获取原文
           

摘要

The explosive introduction of Chikungunya in the Caribbean and imported cases in the United States, the rapid spread of Ebola in West Africa, the clusters of birth defects linked to an epidemic of Zika virus in the Americas, and the increasing endemic spread in parts of West Africa and recent imported cases of Lassa fever in the United Kingdom and Germany illustrate how quickly local outbreaks of infectious diseases can become threats to international public health. Unfortunately, with the exception of a few, there are no drugs or vaccines available for treatment or prevention of re-emerging human viral hemorrhagic infections, thus, surveillance remains the best approach for the early detection of outbreaks. Although, molecular diagnostics continues to evolve very rapidly, and its impact in the diagnosis of infectious viral diseases is undeniable, multiple challenges still remain for the widespread use of cost-effective, validated, and commercially available molecular tools. In this review, we brie?y describe the epidemiology and global expansion of selected re-emerging hemorrhagic fever viruses in recent years, then focus on the clinical features and the laboratory testing for the diseases. In particular, we re?ect on new learnings during recent outbreak investigations, discuss ongoing research and development priorities and identify further interventions needed for effective control and prevention of these re-emerging viral diseases.
机译:基孔肯雅热在加勒比地区的爆炸性传入和美国的进口病例,埃博拉病毒在西非的迅速蔓延,与寨卡病毒流行有关的先天缺陷簇在美洲以及西非部分地区的流行性传播日益增加非洲和最近在英国和德国进口的拉萨热病例表明,当地的传染病暴发如何迅速威胁国际公共卫生。不幸的是,除少数药物外,没有任何药物或疫苗可用于治疗或预防再次出现的人类病毒性出血性感染,因此,监测仍然是早期发现疾病暴发的最佳方法。尽管分子诊断学继续非常迅速地发展,并且其在传染性病毒疾病诊断中的影响不可否认,但是对于具有成本效益的,经过验证的和可商购的分子工具的广泛使用仍然存在着许多挑战。在这篇综述中,我们简要介绍了近年来精选的重新出现的出血热病毒的流行病学和全球范围的扩展,然后重点介绍了该疾病的临床特征和实验室检测。特别是,我们在最近的暴发调查中反映了新的学习成果,讨论了正在进行的研发重点,并确定了有效控制和预防这些新出现的病毒性疾病所需的进一步干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号